New Atlantic Ventures has closed its third fund with $115 million in capital commitments. The firm focuses on early-stage IT opportunities, and has offices in Cambridge, Mass. and Reston, Virginia.
2 min read · 16 April 2009
Tribal Nova, a Montreal-based creator of of parent-friendly virtual worlds and online educational games for 3-12 year-olds, has raised C$3 million from iNovia Capital and ID Capital.
2 min read · 16 April 2009
Lycera Corp., an Ann Arbor, Mich.-based drug developer focused on autoimmune diseases, has raised $36 million in Series A funding. The deal is tranched-out based on milestones, with Lycera already having called down the first $10 million. InterWest Partners, ARCH Venture Partners and Clarus Ventures co-led the round, with seed backer EDF Ventures also participating.
4 min read · 16 April 2009
TRUSTe, a San Francisco-based provider of online private information, has acquired Haute Secure, a Seattle–based maker of website scanning and anti-malware solutions. No financial terms were disclosed. TRUSTe has raised VC funding from Accel Partners, while Haute Secure was backed by Baseline Ventures, Ron Conway and Ram Shiram.
3 min read · 16 April 2009
Sun Catalytix, a Cambridge, Mass.-based “solar fuel” startup, has raised an undisclosed amount of seed funding from Polaris Venture Partners (VentureExpert database lists the round amount at $700k). The news was first reported by Xconomy, which says that Sun Catalytix is looking to commercialize the research of MIT chemistry professor Daniel Nocera.
1 min read · 16 April 2009
The Mid-Atlantic Venture Association (MAVA) has elected three new directors: Deric Emry of ABS Capital Partners, Jonathan Perl of Boulder Ventures and Tony Ricciardella of Grant Thornton. Each director will serve a three-year term.
3 min read · 16 April 2009
Prometheus Laboratories Inc., a San Diego-based drug and diagnostics company, has invested $8 million of equity into Rosetta Genomics Ltd. (Nasdaq: ROSG), as part of a licensing and collaboration agreement. Under terms of the agreement, Prometheus would receive U.S. rights to three of Rosetta's microRNA-based cancer diagnostic tests. Prometheus currently is in registration for a $100 million IPO, and has raised around $73 million in VC funding from DLJ Merchant Banking Partners (21.4% stake), Split Rock Partners (17.4%), New Leaf Ventures (12.5%), Apax Partners (11%) , Wachovia Capital Partners (11%) and Brentwood Venture Capital (7.5%).
5 min read · 16 April 2009
Photonera, a Sunnyvale, Calif.-based maker of photonics solutions for ultra-dense, high-speed interconnection systems, has acquired Intexys Photonics, a Toulouse, France-based manufacturer of high-speed optical modules. No financial terms were disclosed. Intexys had raised over $7.5 million in VC funding, from firms like Rhone-Alpes Creation, BNP Paribas, CEA Valorisation, IRDI, EmerTec Gestion, LC Capital and UFG Private Equity.
2 min read · 16 April 2009
Macrovision Solutions Corp. (Nasdaq: MVSN) has agreed to acquire the assets of Muze Inc., a New York-based digital content management company, from Enterprise Partners Venture Capital. The deal is valued at $16.5 million in cash, and is expected to close later this month. Enterprise Partners had acquired Muze back in 2005, paying approximately $20 million in equity.
4 min read · 16 April 2009
Century Payments Inc., a Dallas-based acquisition platform focused on the payment processing market, has acquired Birmingham, Ala.-based National Merchant Services Inc. Century Payments was formed by Austin Ventures, which committed up to $50 million. NMS is its fourth acquisition.
3 min read · 15 April 2009
